Matthias Grube
Overview
Explore the profile of Matthias Grube including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
743
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luerken L, Goetz A, Mayr V, Zhang L, Schlitt A, Haimerl M, et al.
Biomedicines
. 2025 Jan;
12(12.
PMID: 39767776
: To report on the first results of safety, efficacy, and outcome of CT-navigated stereotactic percutaneous electrochemotherapy (SpECT) in patients with primary and secondary liver malignancies. : This retrospective study...
2.
Burkhard-Meier A, Grube M, Jurinovic V, Agaimy A, Albertsmeier M, Berclaz L, et al.
Eur J Surg Oncol
. 2024 Sep;
50(12):108619.
PMID: 39270516
Background: Local ablative therapies (LAT) are increasingly used in patients with metastatic soft tissue sarcoma (STS), yet evidence-based standards are lacking. This study aimed to assess the impact of LAT...
3.
Langer R, Lelas A, Rittenschober M, Piekarska A, Sadowska-Klasa A, Sabol I, et al.
Front Transplant
. 2024 Jul;
3:1332181.
PMID: 38993773
Introduction: Chronic graft-versus-host disease (cGvHD) is a serious late complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods: This multicenter analysis determined the cumulative incidence (CI) of cGvHD and late...
4.
Bittrich M, Kriegsmann K, Tietze-Stolley C, Movassaghi K, Grube M, Vucinic V, et al.
Transfus Med Hemother
. 2023 Dec;
50(6):475-490.
PMID: 38089497
Introduction: In patients with a clinical indication for autologous hematopoietic stem cell transplantation (ASCT), sufficient mobilization of CD34 precursor cells into peripheral blood is essential to ensure adequate hematopoietic stem...
5.
Kriegsmann K, Bittrich M, Sauer S, Tietze-Stolley C, Movassaghi K, Grube M, et al.
Transfus Med Hemother
. 2023 Oct;
50(5):403-416.
PMID: 37899991
Introduction: Successful mobilization and collection of peripheral hematopoietic stem cells (HSCs) are necessary for lymphoma patients eligible for myeloablative chemotherapy with subsequent autologous stem cell transplantation (ASCT). Albeit G-CSF alone...
6.
Heudobler D, Luke F, Hahn J, Grube M, Schlosser P, Kremers S, et al.
Haematologica
. 2023 Oct;
109(4):1274-1278.
PMID: 37881883
No abstract available.
7.
Ruegamer T, Harrer D, Simon M, Sandner A, Wolff D, Grube M, et al.
J Clin Microbiol
. 2023 May;
61(5):e0133922.
PMID: 37219091
No abstract available.
8.
Ruegamer T, Harrer D, Simon M, Sandner A, Wolff D, Grube M, et al.
J Clin Microbiol
. 2023 May;
61(5):e0134022.
PMID: 37219090
No abstract available.
9.
Bielack S, Lindner L, Egerer G, Benzler K, Blattmann C, Grube M, et al.
J Geriatr Oncol
. 2023 Feb;
14(3):101445.
PMID: 36842425
Introduction: Osteosarcoma is typically a disease of the young, but may affect any age. Little is known about the disease in older patients beyond retirement age. We aim to describe...
10.
Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhell S, et al.
Br J Cancer
. 2022 Dec;
128(6):1134-1147.
PMID: 36572733
Background: Recently, molecular tumour boards (MTBs) have been integrated into the clinical routine. Since their benefit remains debated, we assessed MTB outcomes in the Comprehensive Cancer Center Ostbayern (CCCO) from...